The Disclaimer Box: What 21 CFR 101.93 Actually Requires Next To A Claim

Sodatide's front panel names three front-of-pack claims about what the product is meant to do, printed alongside the brand name and the capsule count. We have not reproduced the exact wording of those three claims here, because this post is not an audit of their phrasing — it is about a separate, specific requirement that exists because claims like them are printed on the bottle at all: the boxed disclaimer that sits on the same panel.

The reason a dietary supplement is allowed to carry a claim like this without pre-market FDA approval, and the reason it then has to carry a disclaimer, trace back to the same piece of law: the Dietary Supplement Health and Education Act of 1994 (DSHEA). DSHEA created a category of claim — the structure/function claim — that a supplement label can make without the product first being reviewed and approved by FDA the way a drug would be. In exchange for that lighter pre-market burden, the statute and FDA's implementing regulation at 21 CFR 101.93 require the label to say, in effect, that the claim has not been evaluated by FDA and that the product is not a treatment for disease. The disclaimer is the other half of the bargain that lets a structure/function claim appear on a supplement bottle in the first place.

21 CFR 101.93 does more than require the disclaimer's text exist somewhere on the packaging. It sets conditions on how the disclaimer has to be presented so that a reader actually encounters it alongside the claim it qualifies, rather than having to hunt for it. The regulation calls for the statement to be set off in its own enclosure — a box, in practice — printed so that it is easily found and read, and tied to the panel where the claim itself appears rather than relegated to an unrelated part of the packaging where a buyer reading the claim would never see it.

On Sodatide's label, that requirement shows up exactly as the regulation contemplates: a boxed disclaimer sitting on the same front panel as the three claims, not on the ingredient panel on a different side of the bottle and not buried in a paragraph of unrelated marketing copy. That placement is doing real regulatory work, not just following a design convention. A label that printed its structure/function claims on the front and tucked an unboxed disclaimer into small type on the back, disconnected from the claims it is supposed to qualify, would be meeting the letter of “the words appear somewhere” while missing the actual placement and prominence requirement the regulation is built around.

It is worth being precise about what we are and are not asserting here. We have confirmed, from this label's own supplement-facts transcription, that the disclaimer is boxed and that it sits on the same panel as the front claims. We are not in a position to independently verify every formatting detail FDA's guidance discusses — type size relative to other text, for instance — without the physical label in hand to measure. What we can say with confidence is that the placement this label uses is the placement the rule is designed to produce: claim and disclaimer, together, where a reader sees both.

It is also worth noting what happens when a label gets this placement wrong, because the consequence clarifies why the rule exists in the first place. A structure/function claim printed without any accompanying disclaimer, or with a disclaimer relegated to a crowded ingredient panel on a different face of the bottle, does not just risk a technical labeling violation on paper — it defeats the actual purpose of the rule, which is that a shopper reading the claim encounters the qualifying language in the same glance. A disclaimer a reader never sees because it was placed somewhere a reader was never looking is, functionally, no disclaimer at all, regardless of whether the required sentence exists on the packaging somewhere. Placement is not a formality layered on top of the real requirement; for a rule whose entire purpose is informing a reader at the point they encounter a claim, placement is a large part of the real requirement.

The disclaimer's scope is also narrower than it can appear at a glance. It addresses the structure/function claims specifically: it says FDA has not evaluated those statements, and that the product is not intended to diagnose, treat, cure or prevent disease. It does not speak to, and should not be read as commentary on, other parts of the label entirely governed by different rules — the Supplement Facts panel's ingredient amounts, for instance, which are a factual declaration governed by 21 CFR 101.36 and checkable against the product independent of anything the disclaimer says, or the allergen and other-ingredients statements, which carry their own separate accuracy obligations.

In other words, a reader should not treat the disclaimer as a blanket hedge that reduces confidence in everything else on the bottle. It is a specific, required qualifier attached to a specific category of claim, sitting in a specific required location. The ingredient amounts on the panel either match what is actually in the capsule or they do not, and that question is unaffected by whether the structure/function claims on the front panel are strongly or weakly supported by evidence — the two parts of the label are doing different jobs and are governed by different rules.

The same separation applies to the handful of other boxed or bordered elements that can appear on a supplement package, and it is worth naming the general principle rather than treating each one as a special case. A caution block, a storage instruction, an allergen statement and the FDA disclaimer can all share the visual language of a bordered panel — a box, a rule line, bold type — because that visual language signals “read this carefully” regardless of which specific regulation put the text there. The box tells a reader where to look. It does not tell a reader, by itself, which regulation is behind the text inside it, or whether that text is a warning, a required disclaimer, or a simple fact. That has to be read, not inferred from the formatting alone.